Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Four hundred myopic children randomly received atropine 0.02% (n = 138) or 0.01% (n = 142) in both eyes once-nightly or only wore single-vision spectacles (control group) (n = 120) for 2 years. Spherical equivalent refractive error (SER), axial length (AL), pupil diameter (PD), and amplitude of acco...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2021-11, Vol.11 (1), p.22267-22267, Article 22267
Hauptverfasser:	Cui, Can, Li, Xiujuan, Lyu, Yong, Wei, Li, Zhao, Bingxin, Yu, Shiao, Rong, Junbo, Bai, Yanhui, Fu, Aicun
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/2779/777 692/699/3161/3174 Atropine Atropine - administration & dosage Atropine - adverse effects Case-Control Studies Child Disease Management Female Humanities and Social Sciences Humans Male multidisciplinary Multidisciplinary Sciences Mydriatics - administration & dosage Mydriatics - adverse effects Myopia Myopia, Degenerative - diagnosis Myopia, Degenerative - drug therapy Refraction, Ocular - drug effects Science Science & Technology Science & Technology - Other Topics Science (multidisciplinary) Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!